Clinical Development Rigel continues to advance its Phase 1b clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of...
Reports
SINGAPORE – Media OutReach Newswire – 8 July 2025 – Jollibee Group (PSE: JFC), one of the world’s largest and...
The start of the new year is the perfect time to plan your next big trip, but booking one can...
FREMONT, Calif., August 08, 2024--(BUSINESS WIRE)--Amprius Technologies, Inc. ("Amprius"), (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon...
